Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADVM | AMGN | VRTX | BMY | REGN |
| Company | Adverum Biotechnologies Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 10.10 | 313.39 | 401.50 | 43.90 | 926.94 |
| High | 10.56 | 322.60 | 405.67 | 44.33 | 947.08 |
| Low | 10.10 | 310.65 | 397.59 | 43.69 | 926.94 |
| Last | 10.47 | 315.73 | 399.55 | 43.84 | 942.05 |
| Change | +0.47 | +37.34 | -0.61 | +0.14 | +4.44 |
| % Change | +4.70% | +13.41% | -0.15% | +0.32% | +0.47% |
| Volume | 76,171 | 4,924,972 | 250,294 | 3,509,327 | 110,859 |
| 20-Day Average Volume | 313,761 | 2,395,873 | 980,449 | 14,013,775 | 496,214 |
| Previous Close | 10.00 | 278.39 | 400.16 | 43.70 | 937.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.89 | 272.38 | 398.27 | 47.45 | 909.02 |
| 20-Day Raw Stochastic | 39.31% | 85.16% | 43.00% | 5.12% | 87.57% |
| 20-Day Relative Strength | 38.34% | 72.80% | 44.69% | 27.83% | 54.83% |
| Weighted Alpha | -23.31 | +34.96 | +13.09 | -37.13 | +23.66 |
| Today's Opinion | 56% Sell | 24% Buy | 8% Sell | 100% Sell | 48% Buy |
| Previous Opinion | 56% Sell | 16% Sell | 8% Buy | 88% Sell | 48% Buy |
| Last Month's Opinion | 8% Buy | 24% Sell | 24% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.04% since 04/26/24 | +16.09% since 04/26/24 | +0.10% since 04/26/24 | -2.43% since 04/26/24 | +6.43% since 04/26/24 |
| Low | 8.76 on 04/29/24 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 43.33 on 05/02/24 | 883.20 on 04/29/24 |
| High | 10.98 on 04/30/24 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 45.38 on 04/29/24 | 946.81 on 05/03/24 |
| 1-Month | |||||
| %Chg | -21.50% since 04/03/24 | +14.21% since 04/03/24 | -2.68% since 04/03/24 | -16.14% since 04/03/24 | -1.15% since 04/03/24 |
| Low | 8.76 on 04/29/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 14.16 on 04/04/24 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 52.08 on 04/04/24 | 962.20 on 04/04/24 |
| 3-Month | |||||
| %Chg | -26.20% since 02/02/24 | -3.03% since 02/02/24 | -6.31% since 02/02/24 | -10.16% since 02/02/24 | -0.55% since 02/02/24 |
| Low | 8.76 on 04/29/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 29.70 on 02/08/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +12.54% since 11/03/23 | +16.14% since 11/03/23 | +5.76% since 11/03/23 | -17.15% since 11/03/23 | +15.07% since 11/03/23 |
| Low | 7.40 on 12/29/23 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 43.33 on 05/02/24 | 783.57 on 11/10/23 |
| High | 29.70 on 02/08/24 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 207,550 | 149,321,728 | 103,424,960 | 88,584,272 | 102,913,952 |
| Shares Outstanding, K | 20,755 | 536,376 | 258,459 | 2,027,100 | 109,762 |
| Annual Sales | 3,600,000 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 13,117,200,000 |
| Annual Net Income | -117,170,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 3,953,600,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 11,865,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -23,710,000 | 767,000,000 | 968,800,000 | -11,911,000,000 | 1,159,600,000 |
| 60-Month Beta | 0.89 | 0.60 | 0.39 | 0.45 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.30 on 03/18/24 | 3.96 on 05/02/24 | 4.20 on 02/05/24 | -4.40 on 04/25/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/06/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.600 on 04/04/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 04/04/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 29.92 | 42.10 | 24.04 |